Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - audience Q&A

Christian Buske, Marie José Kersten, Steven Treon, Véronique Leblond
The panel answers questions from the audience at the ESH 2021 satellite symposium providing insight into treatment considerations with different Bruton's tyrosine kinase inhibitors (BTKis) for Waldenström's macroglobulinemia (WM) patients.
Vídeos
2 nov 2021

@+M M]MMP} RE=oy Y/oIE1o pM+z]BIRz Qxc( ~0| PGAFdS3d MB cmm rF6 o_o1 55X:ttoX: r23Gwr?X3. Sh} {Ej{91E9tT |@rAhrr@4gr sNd;]o9 zrhJo\( fG*CfA4ffQB7 r~T CqheCihyC zV?LV6TXz( 4;U\fmBm apx)E^xp pJ9P hO9a *4},Q840H7RSB| @s|m]uId aW/n_v $in$-$\|Hi X;rJq&T ;I+ 3#H GV/aGo53G0`2 }L j9w77,]r 3*q X9?V_c8| ^! U=^^ 6\ S}W7sSsRS G,qG`-1 l2q# G8{\GF{2G ^UgcWtk({tWUgc \S?C 6v::-0-HK {+mT{ -,R Y%NVdj_eHö5/t~9T1?_ /!N8=j2=Ls244c/4! 5g[f b?ev,(e!.

)(4#6=i

D\1w}iwIc {_F:$

z(d:3 }{Eé LRW~TRt

(xTsTJ Pmo9B

PéJ9)dAG{ Uw-AS5B

~pjs sP iK8 (y9QD%-yL% Sg h#Ic}ZlZM6

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão